Uncategorized Archives - Page 81 of 232

ThursdayDec 05, 2019 11:56 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Edible Drug Delivery Platform Even Faster

Lexaria Bioscience is a company that is passionate about establishing alternatives to inhalation for rapid-response drug substance delivery in order to eliminate the lung harm that smoking or vaping may cause Lexaria’s DehydraTECH platform has generated numerous patents with more pending as a way to provide quick substance delivery to the user’s bloodstream and better access through the blood-brain barrier Lexaria recently announced it had further improved DehydraTECH, as demonstrated in testing that showed early pilot-stage human trial participants began to note edible THC effects in under 10 minutes – more rapidly than the previous DehydraTECH formulation Prior technology testing…

ThursdayDec 05, 2019 9:00 am

UCSD Researchers Study Possible Benefits and Risks of Cannabidiol

Cannabidiol (CBD) has achieved what very few products have. From being barely known, CBD has grown so quickly that it is estimated the cannabidiol market will be worth at least $20 billion in sales by 2026. However, there's a good reason why most new products have to go through a lengthy approval period before hitting the shelves. Especially products that claim to cure a variety of diseases. Given the sheer amount of CBD products on the market right now, estimated to be in the thousands, one would think that regulatory authorities have properly vetted and approved them. The truth is,…

WednesdayDec 04, 2019 4:00 pm

How Long Can CBD Last Before Going Bad?

Cannabidiol (CBD) is all the rage these days. From a compound that was almost unknown three years ago, it has grown into an industry worth billions, and it's expected to grow even bigger in the coming years. The hemp extract's popularity is due to its ability to work against a wide variety of medical conditions. The list is almost unending, and it includes anxiety, high blood pressure, and chronic pain. There's even a CBD-based drug approved by the U.S. Food and Drug Administration (FDA) to treat seizures in severe and hard to manage pediatric epilepsies. But, does cannabidiol go bad?…

WednesdayDec 04, 2019 2:19 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds

DehydraTECH™ is patent protected for multiple Active Pharmaceutical Ingredients (APIs) including hemp oil CBD and cannabis, nicotine, non-steroidal anti-inflammatory drugs, and fat-soluble vitamins Lexaria has 16 patents granted and over 60 patent applications pending worldwide DehydraTECH™ shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is accelerating its patented DehydraTECH based drug delivery technology and formulation development. Funding received from the first tranche of Lexaria’s previously announced private placement of units, issued at a price of $0.45 per unit, realized gross…

WednesdayDec 04, 2019 1:23 pm

No Borders Inc. (NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results

CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues…

WednesdayDec 04, 2019 11:38 am

HTC Extraction Systems (TSX.V: HTC) Acquisition Augments Company’s Output Capability

HTC acquires California-based Kase Farma Inc. HTC Extraction Systems announces tolling contracts, project progress and more Hemp-derived CBD market set to grow to $22 billion by 2022 With the acquisition of a company engaged in the extraction, purification and wholesale distribution of hemp-based cannabinoid extracts, HTC Extraction Systems (TSX.V: HTC) has bolstered its output capability and institutional knowledge considerably. The acquired entity – Kase Farma Inc. of Ceres, California – is currently expanding and upgrading its extraction, refining and processing operations. Kase Farma will enter into an intellectual property licensing agreement with Starling Brands Inc., the vendor. Under this licensing…

WednesdayDec 04, 2019 9:00 am

Why Some People May Cough When They Vape CBD

Cannabidiol (CBD) has been having a ton of good press over the past few years. Extracted from legal industrial hemp, the compound is choke-full of potent medicinal properties, perfectly capable of kicking a variety of conditions to the curb. The long list of medical conditions CBD is effective against ranges from insomnia and anxiety to severe issues like chronic pain and pediatric epilepsy. Aside from its medical benefits, cannabidiol can be used in diverse ways, ranging from tinctures, edibles, and topicals to vaping. Arguably, vaping is the fastest way to experience the effects of CBD since it doesn’t have to…

TuesdayDec 03, 2019 4:00 pm

FDA Releases Revised CBD Consumer Update

The CBD industry has undergone massive growth since the 2018 Hemp Farming Act made the cultivation of industrial hemp legal. Driven by immense demand for hemp extract cannabidiol, the sector has grown extremely quickly in quite a limited span of time, and regulatory authorities have been left scrambling to catch up. In a bid to rein in a sector that some have dubbed a wild west, the U.S. Food and Drug Administration has sent a second batch of warning letters to several companies that sell CBD-infused products. The 15 companies were cautioned against the illegal sale of cannabidiol products that…

TuesdayDec 03, 2019 12:33 pm

LiveWire Ergogenics Inc. (LVVV) Takes Unique ‘Family-Farm Style’ Approach to Cannabis Industry

LiveWire plans on transforming new 265-acre ranch in Paso Robles into central base LiveWire implements unique business model that CEO believes gives company edge in booming cannabis industry Hodson compares company’s approach in cannabis industry to successful business model in established wine industry LiveWire Ergogenics Inc. (OTC: LVVV) is an innovative company in the health and wellness industry that focuses on identifying and monetizing trends through special-purpose real-estate acquisitions. The Anaheim, California-based company is gaining traction in the cannabis industry with its foundational emphasis on ‘doing it right’ (http://cnw.fm/8Pgqi). Today, CBD is one of the most prominent products in the health…

TuesdayDec 03, 2019 9:00 am

CBD Companies Say Lack of FDA Rules is Hurting Their Businesses

The cannabidiol (CBD) industry has seen massive growth in the past few years. Valued at $1.8 billion in 2018, the US CBD market is expected to hit $16.32 billion by 2026, a compound annual growth rate of 27.7%. The genesis can be traced back to the 2018 Hemp Farming Act, legislation that legalized the cultivation of industrial hemp, the plant from which cannabidiol, touted as a miracle drug, is extracted. Bolstered by this regulation, tons of sellers streamed into the industry, some dealing in hemp farming and others dealing with the CBD end. However, despite the fact that there is…